Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population
Abstract BACKGROUND The appearance of left ventricular hypertrophy on 12-lead electrocardiography (ECG-LVH) has been clarified to be associated with the risk of incidence of cardiovascular events (CVEs) in hypertensive individuals and the general population, but not enough in non-hypertensive indivi...
Gespeichert in:
Veröffentlicht in: | American journal of hypertension 2018-07, Vol.31 (8), p.895-901 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 901 |
---|---|
container_issue | 8 |
container_start_page | 895 |
container_title | American journal of hypertension |
container_volume | 31 |
creator | Tanaka, Kentaro Tanaka, Fumitaka Onoda, Toshiyuki Tanno, Kozo Ohsawa, Masaki Sakata, Kiyomi Omama, Shinichi Ogasawara, Kuniaki Ishibashi, Yasuhiro Itai, Kazuyoshi Kuribayashi, Toru Okayama, Akira Nakamura, Motoyuki |
description | Abstract
BACKGROUND
The appearance of left ventricular hypertrophy on 12-lead electrocardiography (ECG-LVH) has been clarified to be associated with the risk of incidence of cardiovascular events (CVEs) in hypertensive individuals and the general population, but not enough in non-hypertensive individuals.
METHODS
A total of 4,927 non-hypertensive individuals ≥40 years of age who were free of CVE in the general population were followed for the incidence of CVE. ECG-LVH was defined according to criteria of the Sokolow-Lyon (SL) voltage, Cornell voltage (CV), or Cornell voltage product (CP).
RESULTS
During the average 9.8 ± 2.0 years of follow-up, 267 individuals (5.4%) had their first CVE. The hazard ratio (HR) for the incidence of CVE after full adjustment by potential confounders significantly increased in the individuals with ECG-LVH by any criteria of the SL voltage, CV, and CP (HR = 1.77, P < 0.001) compared to those with no ECG-LVH. This association was also significant in individuals without any of obesity, dyslipidemia, and diabetes mellitus or those with systolic blood pressure (BP) |
doi_str_mv | 10.1093/ajh/hpy055 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2026408180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ajh/hpy055</oup_id><sourcerecordid>2026408180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-785edca60104b71b51788c5f9f173d29774eab721f69dc85a30e8b09b0c8502a3</originalsourceid><addsrcrecordid>eNp90MFO3DAQBmCrApWF9tIHqHypVCGFHWfjOD6WFQWkFayqlmvkOBPWNLGDnSDlIXhnDAGOSJZG1nzzH35CvjE4YSBXS3W3W-76CTj_RBZMZiwRacr3yAIKyRMBOTsghyHcAUCW5-wzOUhlzuMTC_K49e7WujAYTW9UOyJ1DT1rUQ_eaeVr42696ndxu8FmoDdoB2_02CpPL6YefWT9bqLO0vWLflBh3v4x4T81lip65WwyW7TBPCBdu64brRmm5FQFrOnW9fFkMM5-IfuNagN-fZ1H5N_vs7_ri2RzfX65_rVJdMbkkIiCY61VDgyySrCKM1EUmjeyYWJVp1KIDFUlUtbkstYFVyvAogJZQfxAqlZH5Oec23t3P2IYys4EjW2rLLoxlCmkeQYFKyDS45lq70Lw2JS9N53yU8mgfK6_jPWXc_0Rf3_NHasO63f61ncEP2bgxv6joCebm5EJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2026408180</pqid></control><display><type>article</type><title>Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Tanaka, Kentaro ; Tanaka, Fumitaka ; Onoda, Toshiyuki ; Tanno, Kozo ; Ohsawa, Masaki ; Sakata, Kiyomi ; Omama, Shinichi ; Ogasawara, Kuniaki ; Ishibashi, Yasuhiro ; Itai, Kazuyoshi ; Kuribayashi, Toru ; Okayama, Akira ; Nakamura, Motoyuki</creator><creatorcontrib>Tanaka, Kentaro ; Tanaka, Fumitaka ; Onoda, Toshiyuki ; Tanno, Kozo ; Ohsawa, Masaki ; Sakata, Kiyomi ; Omama, Shinichi ; Ogasawara, Kuniaki ; Ishibashi, Yasuhiro ; Itai, Kazuyoshi ; Kuribayashi, Toru ; Okayama, Akira ; Nakamura, Motoyuki ; Iwate-Kenco Study Group</creatorcontrib><description>Abstract
BACKGROUND
The appearance of left ventricular hypertrophy on 12-lead electrocardiography (ECG-LVH) has been clarified to be associated with the risk of incidence of cardiovascular events (CVEs) in hypertensive individuals and the general population, but not enough in non-hypertensive individuals.
METHODS
A total of 4,927 non-hypertensive individuals ≥40 years of age who were free of CVE in the general population were followed for the incidence of CVE. ECG-LVH was defined according to criteria of the Sokolow-Lyon (SL) voltage, Cornell voltage (CV), or Cornell voltage product (CP).
RESULTS
During the average 9.8 ± 2.0 years of follow-up, 267 individuals (5.4%) had their first CVE. The hazard ratio (HR) for the incidence of CVE after full adjustment by potential confounders significantly increased in the individuals with ECG-LVH by any criteria of the SL voltage, CV, and CP (HR = 1.77, P < 0.001) compared to those with no ECG-LVH. This association was also significant in individuals without any of obesity, dyslipidemia, and diabetes mellitus or those with systolic blood pressure (BP) <120 mm Hg and diastolic BP <80 mm Hg. Furthermore, ECG-LVH by each criteria provided the reclassification improvement for the CVE risk prediction model by the Framingham 10-year risk score (the net reclassification improvement = 0.17–0.22, each P value < 0.010).
CONCLUSIONS
In the absence of hypertension, ECG-LVH parameters are associated with the increased risk of developed CVEs independent of the established risk factors and provide the additional prognostic value in an assessment of the CVE risk using the traditional risk factors.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1093/ajh/hpy055</identifier><identifier>PMID: 29659657</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>American journal of hypertension, 2018-07, Vol.31 (8), p.895-901</ispartof><rights>American Journal of Hypertension, Ltd 2018. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-785edca60104b71b51788c5f9f173d29774eab721f69dc85a30e8b09b0c8502a3</citedby><cites>FETCH-LOGICAL-c419t-785edca60104b71b51788c5f9f173d29774eab721f69dc85a30e8b09b0c8502a3</cites><orcidid>0000-0002-3520-3305</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29659657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanaka, Kentaro</creatorcontrib><creatorcontrib>Tanaka, Fumitaka</creatorcontrib><creatorcontrib>Onoda, Toshiyuki</creatorcontrib><creatorcontrib>Tanno, Kozo</creatorcontrib><creatorcontrib>Ohsawa, Masaki</creatorcontrib><creatorcontrib>Sakata, Kiyomi</creatorcontrib><creatorcontrib>Omama, Shinichi</creatorcontrib><creatorcontrib>Ogasawara, Kuniaki</creatorcontrib><creatorcontrib>Ishibashi, Yasuhiro</creatorcontrib><creatorcontrib>Itai, Kazuyoshi</creatorcontrib><creatorcontrib>Kuribayashi, Toru</creatorcontrib><creatorcontrib>Okayama, Akira</creatorcontrib><creatorcontrib>Nakamura, Motoyuki</creatorcontrib><creatorcontrib>Iwate-Kenco Study Group</creatorcontrib><title>Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population</title><title>American journal of hypertension</title><addtitle>Am J Hypertens</addtitle><description>Abstract
BACKGROUND
The appearance of left ventricular hypertrophy on 12-lead electrocardiography (ECG-LVH) has been clarified to be associated with the risk of incidence of cardiovascular events (CVEs) in hypertensive individuals and the general population, but not enough in non-hypertensive individuals.
METHODS
A total of 4,927 non-hypertensive individuals ≥40 years of age who were free of CVE in the general population were followed for the incidence of CVE. ECG-LVH was defined according to criteria of the Sokolow-Lyon (SL) voltage, Cornell voltage (CV), or Cornell voltage product (CP).
RESULTS
During the average 9.8 ± 2.0 years of follow-up, 267 individuals (5.4%) had their first CVE. The hazard ratio (HR) for the incidence of CVE after full adjustment by potential confounders significantly increased in the individuals with ECG-LVH by any criteria of the SL voltage, CV, and CP (HR = 1.77, P < 0.001) compared to those with no ECG-LVH. This association was also significant in individuals without any of obesity, dyslipidemia, and diabetes mellitus or those with systolic blood pressure (BP) <120 mm Hg and diastolic BP <80 mm Hg. Furthermore, ECG-LVH by each criteria provided the reclassification improvement for the CVE risk prediction model by the Framingham 10-year risk score (the net reclassification improvement = 0.17–0.22, each P value < 0.010).
CONCLUSIONS
In the absence of hypertension, ECG-LVH parameters are associated with the increased risk of developed CVEs independent of the established risk factors and provide the additional prognostic value in an assessment of the CVE risk using the traditional risk factors.</description><issn>0895-7061</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp90MFO3DAQBmCrApWF9tIHqHypVCGFHWfjOD6WFQWkFayqlmvkOBPWNLGDnSDlIXhnDAGOSJZG1nzzH35CvjE4YSBXS3W3W-76CTj_RBZMZiwRacr3yAIKyRMBOTsghyHcAUCW5-wzOUhlzuMTC_K49e7WujAYTW9UOyJ1DT1rUQ_eaeVr42696ndxu8FmoDdoB2_02CpPL6YefWT9bqLO0vWLflBh3v4x4T81lip65WwyW7TBPCBdu64brRmm5FQFrOnW9fFkMM5-IfuNagN-fZ1H5N_vs7_ri2RzfX65_rVJdMbkkIiCY61VDgyySrCKM1EUmjeyYWJVp1KIDFUlUtbkstYFVyvAogJZQfxAqlZH5Oec23t3P2IYys4EjW2rLLoxlCmkeQYFKyDS45lq70Lw2JS9N53yU8mgfK6_jPWXc_0Rf3_NHasO63f61ncEP2bgxv6joCebm5EJ</recordid><startdate>20180716</startdate><enddate>20180716</enddate><creator>Tanaka, Kentaro</creator><creator>Tanaka, Fumitaka</creator><creator>Onoda, Toshiyuki</creator><creator>Tanno, Kozo</creator><creator>Ohsawa, Masaki</creator><creator>Sakata, Kiyomi</creator><creator>Omama, Shinichi</creator><creator>Ogasawara, Kuniaki</creator><creator>Ishibashi, Yasuhiro</creator><creator>Itai, Kazuyoshi</creator><creator>Kuribayashi, Toru</creator><creator>Okayama, Akira</creator><creator>Nakamura, Motoyuki</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3520-3305</orcidid></search><sort><creationdate>20180716</creationdate><title>Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population</title><author>Tanaka, Kentaro ; Tanaka, Fumitaka ; Onoda, Toshiyuki ; Tanno, Kozo ; Ohsawa, Masaki ; Sakata, Kiyomi ; Omama, Shinichi ; Ogasawara, Kuniaki ; Ishibashi, Yasuhiro ; Itai, Kazuyoshi ; Kuribayashi, Toru ; Okayama, Akira ; Nakamura, Motoyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-785edca60104b71b51788c5f9f173d29774eab721f69dc85a30e8b09b0c8502a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Kentaro</creatorcontrib><creatorcontrib>Tanaka, Fumitaka</creatorcontrib><creatorcontrib>Onoda, Toshiyuki</creatorcontrib><creatorcontrib>Tanno, Kozo</creatorcontrib><creatorcontrib>Ohsawa, Masaki</creatorcontrib><creatorcontrib>Sakata, Kiyomi</creatorcontrib><creatorcontrib>Omama, Shinichi</creatorcontrib><creatorcontrib>Ogasawara, Kuniaki</creatorcontrib><creatorcontrib>Ishibashi, Yasuhiro</creatorcontrib><creatorcontrib>Itai, Kazuyoshi</creatorcontrib><creatorcontrib>Kuribayashi, Toru</creatorcontrib><creatorcontrib>Okayama, Akira</creatorcontrib><creatorcontrib>Nakamura, Motoyuki</creatorcontrib><creatorcontrib>Iwate-Kenco Study Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Kentaro</au><au>Tanaka, Fumitaka</au><au>Onoda, Toshiyuki</au><au>Tanno, Kozo</au><au>Ohsawa, Masaki</au><au>Sakata, Kiyomi</au><au>Omama, Shinichi</au><au>Ogasawara, Kuniaki</au><au>Ishibashi, Yasuhiro</au><au>Itai, Kazuyoshi</au><au>Kuribayashi, Toru</au><au>Okayama, Akira</au><au>Nakamura, Motoyuki</au><aucorp>Iwate-Kenco Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population</atitle><jtitle>American journal of hypertension</jtitle><addtitle>Am J Hypertens</addtitle><date>2018-07-16</date><risdate>2018</risdate><volume>31</volume><issue>8</issue><spage>895</spage><epage>901</epage><pages>895-901</pages><issn>0895-7061</issn><eissn>1941-7225</eissn><abstract>Abstract
BACKGROUND
The appearance of left ventricular hypertrophy on 12-lead electrocardiography (ECG-LVH) has been clarified to be associated with the risk of incidence of cardiovascular events (CVEs) in hypertensive individuals and the general population, but not enough in non-hypertensive individuals.
METHODS
A total of 4,927 non-hypertensive individuals ≥40 years of age who were free of CVE in the general population were followed for the incidence of CVE. ECG-LVH was defined according to criteria of the Sokolow-Lyon (SL) voltage, Cornell voltage (CV), or Cornell voltage product (CP).
RESULTS
During the average 9.8 ± 2.0 years of follow-up, 267 individuals (5.4%) had their first CVE. The hazard ratio (HR) for the incidence of CVE after full adjustment by potential confounders significantly increased in the individuals with ECG-LVH by any criteria of the SL voltage, CV, and CP (HR = 1.77, P < 0.001) compared to those with no ECG-LVH. This association was also significant in individuals without any of obesity, dyslipidemia, and diabetes mellitus or those with systolic blood pressure (BP) <120 mm Hg and diastolic BP <80 mm Hg. Furthermore, ECG-LVH by each criteria provided the reclassification improvement for the CVE risk prediction model by the Framingham 10-year risk score (the net reclassification improvement = 0.17–0.22, each P value < 0.010).
CONCLUSIONS
In the absence of hypertension, ECG-LVH parameters are associated with the increased risk of developed CVEs independent of the established risk factors and provide the additional prognostic value in an assessment of the CVE risk using the traditional risk factors.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>29659657</pmid><doi>10.1093/ajh/hpy055</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3520-3305</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0895-7061 |
ispartof | American journal of hypertension, 2018-07, Vol.31 (8), p.895-901 |
issn | 0895-7061 1941-7225 |
language | eng |
recordid | cdi_proquest_miscellaneous_2026408180 |
source | Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
title | Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A12%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Value%20of%20Electrocardiographic%20Left%20Ventricular%20Hypertrophy%20on%20Cardiovascular%20Risk%20in%20a%20Non-Hypertensive%20Community-Based%20Population&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Tanaka,%20Kentaro&rft.aucorp=Iwate-Kenco%20Study%20Group&rft.date=2018-07-16&rft.volume=31&rft.issue=8&rft.spage=895&rft.epage=901&rft.pages=895-901&rft.issn=0895-7061&rft.eissn=1941-7225&rft_id=info:doi/10.1093/ajh/hpy055&rft_dat=%3Cproquest_cross%3E2026408180%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2026408180&rft_id=info:pmid/29659657&rft_oup_id=10.1093/ajh/hpy055&rfr_iscdi=true |